91 related articles for article (PubMed ID: 30497857)
1. Prolonged partial thromboplastin time: To mix or not to mix - is that the question?
Yates SG; Fitts E; De Simone N; Sarode R
Transfus Apher Sci; 2019 Feb; 58(1):39-42. PubMed ID: 30497857
[TBL] [Abstract][Full Text] [Related]
2. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.
Kershaw G; Orellana D
Semin Thromb Hemost; 2013 Apr; 39(3):283-90. PubMed ID: 23457048
[TBL] [Abstract][Full Text] [Related]
3. Lupus anticoagulant increases activated partial thromboplastin time (PTT) prolongation in incubated 1:1 mix.
Monis G; Ferrell C; Reyes M
Clin Lab Sci; 2012; 25(3):165-9. PubMed ID: 22953516
[TBL] [Abstract][Full Text] [Related]
4. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
Al-Mondhiry H; Galanakis D
J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
[TBL] [Abstract][Full Text] [Related]
5. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
Depreter B; Devreese KM
Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
[TBL] [Abstract][Full Text] [Related]
6. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
[TBL] [Abstract][Full Text] [Related]
7. Mixing studies for lupus anticoagulant: does it matter how we mix?
Radišić Biljak V; Tomas M; Lapić I
Blood Coagul Fibrinolysis; 2024 Apr; 35(3):129-132. PubMed ID: 38358906
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.
Chen J; Phillips B; Chandler WL
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):90-6. PubMed ID: 26397883
[TBL] [Abstract][Full Text] [Related]
9. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
10. The laboratory diagnosis of lupus anticoagulants.
Lazarchick J; Kizer J
Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
[TBL] [Abstract][Full Text] [Related]
11. Performance and Interpretation of Mixing Tests in Coagulation.
Kershaw G
Methods Mol Biol; 2017; 1646():85-90. PubMed ID: 28804820
[TBL] [Abstract][Full Text] [Related]
12. A "percent correction" formula for evaluation of mixing studies.
Chang SH; Tillema V; Scherr D
Am J Clin Pathol; 2002 Jan; 117(1):62-73. PubMed ID: 11789732
[TBL] [Abstract][Full Text] [Related]
13. Coagulation Testing in the Core Laboratory.
Winter WE; Flax SD; Harris NS
Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
[TBL] [Abstract][Full Text] [Related]
14. The laboratory heterogeneity of lupus anticoagulants.
Triplett DA; Brandt JT; Maas RL
Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
[TBL] [Abstract][Full Text] [Related]
15. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
Chandrashekar V
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
[TBL] [Abstract][Full Text] [Related]
16. The isolated prolonged PTT.
Tcherniantchouk O; Laposata M; Marques MB
Am J Hematol; 2013 Jan; 88(1):82-5. PubMed ID: 22811044
[TBL] [Abstract][Full Text] [Related]
17. Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).
Tripodi A; Chantarangkul V
Methods Mol Biol; 2017; 1646():177-183. PubMed ID: 28804829
[TBL] [Abstract][Full Text] [Related]
18. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
[TBL] [Abstract][Full Text] [Related]
19. Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partial thromboplastin time, and thrombin generation assay.
Morishima Y; Kamisato C
Am J Clin Pathol; 2015 Feb; 143(2):241-7. PubMed ID: 25596250
[TBL] [Abstract][Full Text] [Related]
20. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
